Renal clearance of substituted hippurates in the dog. I. Benzoylglycine (hippurate) and methyl-substituted benzoylglycines
- PMID: 2913286
Renal clearance of substituted hippurates in the dog. I. Benzoylglycine (hippurate) and methyl-substituted benzoylglycines
Abstract
Plasma kinetics and renal excretion of benzoylglycine (hippurate) and methyl-substituted benzoylglycines were studied in three Beagle dogs, after rapid i.v. administration of about 1 g of glycine conjugate. Benzoylglycine and the 3- and 4-methyl analogs showed nonlinear plasma protein binding varying between 20 and 80% over a concentration range of 5 to 450 micrograms/ml. For 2-methylbenzoylglycine an extremely high protein binding, practically approaching 100%, was observed at low plasma levels (less than 50 micrograms/ml). All conjugates were cleared largely via the kidney (greater than 80% of the dose) and, except for the 2-methyl analog, eliminated rapidly from plasma. Plasma concentration and renal excretion rate data were analyzed simultaneously with a previously developed physiologically based kidney model. Tubular secretion appeared to be a function of the total drug concentration in renal plasma, except for 2-methylbenzoylglycine, presumably due to its tight protein binding. The average values of the parameters characterizing the tubular transport maximum (TM in milligrams per minute) and the apparent affinity for the secretory system (KT in micrograms per milliliter) were: benzoylglycine TM = 5.5 +/- 0.8, KT = 40 +/- 5; 3-methylbenzoylglycine TM = 7.1 +/- 3.3, KT = 49 +/- 1; 4-methylbenzoylglycine TM = 8.0 +/- 1.6, KT = 14 +/- 6. Secretion of 2-methylbenzoylglycine was not saturated. Accordingly, only the ratio TM/KT = 163 +/- 54 ml/min could be calculated. An interesting observation was the partial deconjugation of 4-methylbenzoylglycine to its corresponding benzoate.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Renal clearance of substituted hippurates in the dog. II. 4-Amino-, hydroxy- and methoxy-substituted benzoylglycines.J Pharmacol Exp Ther. 1989 Jan;248(1):436-46. J Pharmacol Exp Ther. 1989. PMID: 2913287
-
Differences in excretion of hippurate, as a metabolite of benzoate and as an administered species, in the single-pass isolated perfused rat kidney explained.J Pharmacol Exp Ther. 1999 Feb;288(2):597-606. J Pharmacol Exp Ther. 1999. PMID: 9918564
-
Disposition of 4-methylbenzoylglycine in rat isolated perfused kidney and effects of hippurates on renal mitochondrial metabolism.J Pharm Pharmacol. 1998 Dec;50(12):1397-404. doi: 10.1111/j.2042-7158.1998.tb03366.x. J Pharm Pharmacol. 1998. PMID: 10052856
-
Physiologically based pharmacokinetic model for the renal clearance of salicyluric acid and the interaction with phenolsulfonphthalein in the dog.Drug Metab Dispos. 1987 Sep-Oct;15(5):695-701. Drug Metab Dispos. 1987. PMID: 2891488
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
Cited by
-
A physiological model for renal drug metabolism: enalapril esterolysis to enalaprilat in the isolated perfused rat kidney.J Pharmacokinet Biopharm. 1990 Dec;18(6):561-87. doi: 10.1007/BF01073939. J Pharmacokinet Biopharm. 1990. PMID: 2177788
-
Effect of substituted benzoylglycines (hippurates) and phenylacetylglycines on p-aminohippurate transport in dog renal membrane vesicles.Pharm Res. 1994 Dec;11(12):1829-33. doi: 10.1023/a:1018992106452. Pharm Res. 1994. PMID: 7899251